The early onset of menopause is a known risk factor for primary open angle glaucoma (POAG) with the associated hormonal changes seeming to play an important role. Fjallraven Kanken Big new balance 574 This begged the question of whether postmenopausal hormone therapy could actually play a role in reducing the risk of glaucoma and act in a protective fashion.
Research on Glaucoma Risk & Postmenopausal Hormones
According to researchers publishing in JAMA Ophthalmology taking estrogen only postmenopausal hormone (PMH) treatment may help reduce the risk for primary open-angle glaucoma (POAG). By reviewing data from 152,163 women 50 years or older the researchers found that 1.9 percent of enrollees developed POAG. Adidas Superstar new balance homme Each additional month of use of PMH containing estrogen only was associated with a 0.4 percent reduced risk for POAG whereas each additional month of use of estrogen + progesterone or estrogen + androgen hormones did not affect risk for POAG. bottes ugg pas cher ugg australia classic This is interesting information and will require further clinical studies to understand fully but may offer some novel treatments for primary open angle glaucoma (POAG), an insidious sight threatening eye diseases and the most common type of glaucoma.
If you or someone you know has questions about glaucoma, glaucoma risk factors and the role of postmenopausal hormone therapy in glaucoma risk, or needs to schedule an appointment, please call The Eye Clinic of Texas, an affiliate of Houston Eye Associates, at 800-423-3937, visit The Eye Clinic of Texas or facebook.com/ecot.lasik. nike soldes ugg grise The Eye Clinic of Texas is an affiliate of Houston Eye Associates, the largest ophthalmology clinic in the nation.